Publication
How to Evaluate Fibrosis in IBD?
| dc.contributor.author | Sousa, Helena Tavares | |
| dc.contributor.author | Magro, Fernando | |
| dc.date.accessioned | 2023-09-11T15:49:49Z | |
| dc.date.available | 2023-09-11T15:49:49Z | |
| dc.date.issued | 2023-07 | |
| dc.description.abstract | In this review, we will describe the importance of fibrosis in inflammatory bowel disease (IBD) by discussing its distinct impact on Crohn's disease (CD) and ulcerative colitis (UC) through their translation to histopathology. We will address the existing knowledge on the correlation between inflammation and fibrosis and the still not fully explained inflammation-independent fibrogenesis. Finally, we will compile and discuss the recent advances in the noninvasive assessment of intestinal fibrosis, including imaging and biomarkers. Based on the available data, none of the available cross-sectional imaging (CSI) techniques has proved to be capable of measuring CD fibrosis accurately, with MRE showing the most promising performance along with elastography. Very recent research with radiomics showed encouraging results, but further validation with reliable radiomic biomarkers is warranted. Despite the interesting results with micro-RNAs, further advances on the topic of fibrosis biomarkers depend on the development of robust clinical trials based on solid and validated endpoints. We conclude that it seems very likely that radiomics and AI will participate in the future non-invasive fibrosis assessment by CSI techniques in IBD. However, as of today, surgical pathology remains the gold standard for the diagnosis and quantification of intestinal fibrosis in IBD. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.doi | 10.3390/diagnostics13132188 | pt_PT |
| dc.identifier.eissn | 2075-4418 | |
| dc.identifier.uri | http://hdl.handle.net/10400.1/19961 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | MDPI | pt_PT |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | pt_PT |
| dc.subject | Inflammatory bowel disease | pt_PT |
| dc.subject | Fibrosis | pt_PT |
| dc.subject | Iinflammation | pt_PT |
| dc.subject | imaging | pt_PT |
| dc.subject | Biomarkers | pt_PT |
| dc.title | How to Evaluate Fibrosis in IBD? | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 13 | pt_PT |
| oaire.citation.startPage | 2188 | pt_PT |
| oaire.citation.title | Diagnostics | pt_PT |
| oaire.citation.volume | 13 | pt_PT |
| person.familyName | Sousa | |
| person.givenName | Helena Tavares | |
| person.identifier.ciencia-id | CF1F-1163-1C4A | |
| person.identifier.orcid | 0000-0002-6626-205X | |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 6b1d11dd-486f-4fb3-b41f-02e1cf6a5c2e | |
| relation.isAuthorOfPublication.latestForDiscovery | 6b1d11dd-486f-4fb3-b41f-02e1cf6a5c2e |